Exact Sciences closes takeovers of 2 cancer testing businesses

Exact Sciences has closed the acquisitions of Paradigm Diagnostics and Viomics, adding to its oncology testing capabilities as it looks to expand beyond its flagship Cologuard cancer test.

In a statement Tuesday, Exact Sciences framed the takeovers of the Phoenix, Arizona-based companies as part of efforts to leverage its commercial platform, add to its R&D capabilities and reach more cancer patients.